Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIMUS a Multi-centre, Controlled, Cluster-randomised, Open Study of Multiple Impacts of CDSS Use in Multiple Sclerosis : Real World Usage for Real World Evidence

NCT07647952 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07647952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07647952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIMUS a Multi-centre, Controlled, Cluster-randomised, Open Study of Multiple Impacts of CDSS Use in Multiple Sclerosis : Real World Usage for Real World Evidence
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
July 31, 2028
Enrollment
448 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing - remitting multiple sclerosis